deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT04450693

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

A Multicenter Phase 3 Confirmatory Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

Sponsor: BioTissue Holdings, Inc

Updated 21 times since 2020 Last updated: Mar 26, 2025 Started: Nov 20, 2020 Primary completion: Mar 24, 2025 Completion: Mar 24, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diabetic Foot Infection and Non-healing Diabetic Foot Ulcer, this trial is completed. The trial is conducted by BioTissue Holdings, Inc and has accumulated 21 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jul 2020 – ~Dec 2020 · 5 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Nov 2022 · 12 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Oct 2023 · 8 months · monthly snapshot~Oct 2023 – ~Dec 2023 · 2 months · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Feb 2025 · 4 months · monthly snapshot~Feb 2025 – ~May 2025 · 3 months · monthly snapshot~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. May 2025 — Sep 2025 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  3. Feb 2025 — May 2025 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  4. Oct 2024 — Feb 2025 [monthly]

    Recruiting PHASE3

  5. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE3

Show 16 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  2. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  3. Dec 2023 — Jan 2024 [monthly]

    Recruiting PHASE3

  4. Oct 2023 — Dec 2023 [monthly]

    Recruiting PHASE3

  5. Feb 2023 — Oct 2023 [monthly]

    Recruiting PHASE3

  6. Nov 2022 — Feb 2023 [monthly]

    Recruiting PHASE3

  7. Nov 2021 — Nov 2022 [monthly]

    Recruiting PHASE3

  8. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  9. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  10. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  11. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

  12. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE3

  13. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

  14. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE3

  15. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  16. Jul 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BioTissue Holdings, Inc
Data source: BioTissue Holdings, Inc

For direct contact, visit the study record on ClinicalTrials.gov .